RE: New Broker29 Mar 2021 23:45
It’s a bit chicken and egg with a NASDAQ listing, we may currently not have the PR for a listing over there but we are opening an office there and our next big trial is about to start there “any week now”.
Then there is the other work we are doing with the DoD - “As part of a working relationship established with Faron, the 59(th) Medical Wing of the US Air Force and the DoD will continue primate studies to evaluate Traumakine's role in preventing multiple organ dysfunction syndrome (MODS) after ischemia-reperfusion injury caused by a major trauma.”
It wouldn’t take much positive noise for us to really take off, and the PR machine would be self propelling.
We have shown we can access alternative forms of funding over there, maybe a listing would improve the chances of more such funds?
A Stateside listing wouldn’t have to be dilutive, and it could be a major boost to our SP. Not that we need to fundraise now but it would be nice if the next time we did it was at more like £8+ per share with the backing of some new ii’s from over the pond.
Either way I’m happy to wait and Q3 will be very interesting, but don’t rule out news sooner on the increased frequency dosing of Clevegen the way Markku was speaking in the results presentation these or at least some of these are due very soon.